- €3.60bn
- €6.58bn
- €907.57m
- 49
- 66
- 79
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,153 | 1,054 | 976 | 957 | 908 |
Cost of Revenue | |||||
Gross Profit | 1,034 | 1,012 | 934 | 920 | 871 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 496 | 439 | 392 | 368 | 405 |
Operating Profit | 657 | 615 | 583 | 589 | 502 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 540 | 547 | 500 | 526 | 421 |
Provision for Income Taxes | |||||
Net Income After Taxes | 428 | 445 | 405 | 376 | 343 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 423 | 444 | 404 | 376 | 343 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 423 | 444 | 404 | 376 | 343 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.93 | 1.72 | 1.53 | 1.14 | 1.16 |
Dividends per Share |